08:00 | Registration | |||
09:00 | Inauguration | |||
SESSION 1: NanoPharmaceuticals for Cancer (Session Chair: Ahmed Faheem, Senior Lecturer in Pharmaceutics, University of Sunderland, United Kingdom) | ||||
09:15 |
| |||
10:00 | Nanotechnology for the Treatment of Lung Cancer: The Future of Targeted Therapy | |||
10:35 |
| |||
11:20 | Coffee Break and Networking Session | |||
SESSION 2: Nanotechnology based Drug Delivery Systems (Anand K. Kondapi, Professor, University of Hyderabad, India) | ||||
11:50 | Ocular Delivery to the Posterior Eye using a Novel Nanolipo-Polymeric System In the
first part of the talk, uptake and clearance pathways in the eye will be
discussed. Next part will include discussion on the use of nanostructured systems
to defy the existing ocular barriers so as to reach the internal eye including
the retina. Last part will focus on how they have developed a novel
nanolipo-polymeric system (IPA: 2074/Del/2014), which could reach up to the
retina in an intact form. | |||
12:25 |
| |||
13:10 | Lunch Break and Networking Session | |||
SESSION 3: Nanoparticles for Drug Delivery (Session Chair: Arabinda Chaudhuri, Chief Scientist, CSIR-IICT, India) | ||||
14:10 | Lipid NanoParticle Drug Delivery Systems The presentation covers, selection of formulation ingredients, different methods of preparation of lipid nanoparticles, inclusion of homing devices to achieve targeted drug delivery, characterization of Nano systems, assessment of performance of nanoparticles and applications in pharmaceutical industry.Discussion on specific problems association with formulation, stabilization and manufacturing of these dosage forms will also be presented. Further, regulatory requirements, Quality control, intellectual property and manufacturing issues of NDDS will be presented. Finally, discussion on future research areas and potential of lipid nanoparticle drug delivery systems in industrial applications is presented. | |||
14:45 | Splenotropic Lipomer: Enabling Shape Directed Selective RES Targetting This presentation will present how Asymmetric LIPOMER- lipid
polymer nanostructures of Doxycycline hydrochloride helps in Splenotropic
Delivery. In addition, it will also highlight the process of design and
development of Asymmetric LIPOMER by Nanoprecipitation technique. Further,
it will discuss the role of nanocarrier shape as an important parameter
in Drug Delivery. | |||
15:20 | The Role of Nanoparticle Constructs in Lung and Breast Cancer | |||
15:55 | Coffee Break and Networking Session | |||
SESSION 4: Nanoformulations for Effective Drug Delivery | ||||
16:25 | Targeted Drug Delivery System through Nanoformulations | |||
16:50 | Targeted Drug Delivery to Lung Cancer with Surface Modified and Antibody – Functionalized Chitosan Nanoparticles This talk will focus on targeted delivery of Drug Loaded Chitosan Nanoparticles surface modified with Trastuzumab to the Lung Cancer Cells. Further, it will discuss how these Nanoparticles were functionalized, characterized and kinetics elucidated in vitro using different Lung Cancer Cells. | |||
17:15 | Solubility Enhancement and Formulation of Nanoparticles of Efavirenz using Chitosan-Graft-HPßCD copolymer The
present study will explore a novel method for solubility enhancement of water
insoluble antiretroviral drug Efavirenz by using chitosan –graft-HPßCD
copolymer synthesized by simplified one pot reaction technique and further its
application as carrier for formulation of nanoparticles. | |||
17:30 | End of First Day of Conference |
SESSION 5: Nanotechnology Solutions for Drug Delivery Challenges (Session Chair: Utpal Bhadra, Senior Principal Scientist, CSIR-CCMB, India) | ||||
09:00 |
| |||
09:45 |
| |||
10:30 | Coffee Break and Networking Session | |||
SESSION 6: Advances in Nanotherapeutics | ||||
11:00 | Advanced Nanomaterials for Future Therapeutics This presentation will highlight the advanced
nanomaterials and nanoparticles based drug delivery systems (DDS) for treatment
of cancer, cardiovascular /ischemic disease and wound healing. It will further
highlight the design and development of nanoparticles like europium hydroxide
nanorods (EHNs), zinc oxide nanoflowers (ZON), graphene oxides and gold
nanoparticles that exhibit excellent pro-angiogenic activities. | |||
11:35 |
| |||
12:20 |
| |||
13:05 | Poster Evaluation | |||
13:20 | Lunch Break and Networking Session | |||
SESSION 7: NanoPharmaceuticals for Biologicals and Gene Therapy (Session Chair: Kewal Jain, Chief Executive Officer, Jain PharmaBiotech, Switzerland) | ||||
14:20 | Dual Drug Combination Therapy: Current Prospective and Future Challenges The
presenter will discuss the combinatorial liposomal nanoformulation for
pancreatic cancer based on gemcitabine and ursolic acid, along with the
advantages and future prospective of combinatorial dual drug therapy. | |||
14:45 |
| |||
15:30 | Nanotechnology Based Growth Factors Delivery for Tissue Regeneration This
talk will cover the development of novel nanoencapsulation of protein in to
sugar-glass-matrix (SGnP) to overcome the formidable challenges of Growth
Factors stabilization and their sustained delivery. | |||
16:05 | Coffee Break and Networking Session | |||
SESSION 8: Overcoming Pharmaceutical Issues with Nanoformulations | ||||
16:30 | Biodegradable Polymer Based Depot Injections – Overview and Challenges - Case Studies of Marketed Products | |||
17:05 | Novel, Industrially Feasible Nanocoformulation of Artemether and Clindamycin for Treatment of Malaria in Pregnant Women: A Selective Second Order Targeting Approach | |||
17:20 | Poster Award Presentation & Vote of Thanks | |||
17:30 | End of Conference |